https://orcid.org/0000-0002-9122-8742
References
- Ling-Ling Z, Zhou Q. Polypill brings benefits to patients with cardiovascular disease, both improving medication adherence and demonstrating the concept of chronotherapy [Letter]. Vasc Health Risk Manag. 2023;19:659–660. doi:10.2147/VHRM.S440353
- Lopez-Lopez JP, Gonzalez AM, Lanza P, Lopez-Jaramillo P. Benefits of the polypill on medication adherence in the primary and secondary prevention of cardiovascular disease: a systematic review. Vasc Health Risk Manag. 2023;19:605–615. doi:10.2147/VHRM.S421024
- Lafeber M, Grobbee DE, Schrover IM, et al. Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; a randomized crossover trial. Int J Cardiol. 2015;181:193–199. doi:10.1016/j.ijcard.2014.11.176
- Csoma B, Bikov A. The role of the circadian rhythm in dyslipidemia and vascular inflammation leading to atherosclerosis. Int J Mol Sci. 2023;24(18):14145. doi:10.3390/ijms241814145
- Park S, Ihm SH, Cho IJ, et al. Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension. Clin Hypertens. 2023;29(1):25. doi:10.1186/s40885-023-00249-2